Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Al-izzi, Sara"'
Autor:
Al-izzi, Sara, Baheerathan, Aravindhan, Banerjee, Soma, Benson, Gary, Boshier, Claudia, Buddha, Sandeep, Burley, Nathan, Cameron Smail, Ruaridh, Chandratheva, Arvind, Chudakou, Pavel, Clatworthy, Philip, Coles, Alasdair, Cox, Thomas, Dasgupta, Ranjit, Davenport, Richard, Devine, Darrell, Fenlon, Stephen, Gabriel, Carolyn, Ghatala, Rita, Hall, Claire, Hargovan, Milan, Harkness, Kirsty, Harvey, Ian, Hicken, Lucy, Howaniec, Laura, Ibnouf, Abubaker, Idrovo, Luis, Ingle, Gordon, Kyan Lee, Yong, Lang, Ailidh, McBride, Simon, McLeod, Malcolm, Medlock, Ruth, Mehta, Puja, Morrison, Ian, Muddegowda, Girish, Muzerengi, Sharon, Pang, Donald, Periyasamy, Gopinath, Preston, Gavin, Priestley, Naomi, Revicka, Lydia, Saber, Sadia, Smith, Elliott, Sorour, Youssef, Spooner, Oliver, Stone, Jon, Sztriha, Laszlo, Thambirajah, Narmathey, Thomas, Rhys, Veale, David, Wall, Jasmine, White, Sarah, White, James, Yusoff, Syarah, Zambreanu, Laura, Perry, Richard J *, Tamborska, Arina, Singh, Bhagteshwar, Craven, Brian, Marigold, Richard, Arthur-Farraj, Peter, Yeo, Jing Ming, Zhang, Liqun, Hassan-Smith, Ghaniah, Jones, Matthew, Hutchcroft, Christopher, Hobson, Esther, Warcel, Dana, White, Daniel, Ferdinand, Phillip, Webb, Alastair, Solomon, Tom, Scully, Marie, Werring, David J *, Roffe, Christine *
Publikováno v:
In The Lancet 25 September-1 October 2021 398(10306):1147-1156
Autor:
Joseph, Chitra, Al-Izzi, Sara, Alsaleem, Mansour, Kurozumi, Sasagu, Toss, Michael, Arshad, Maariya, Goh, Fang Qin, Alshankyty, Ibraheem M, Ali, Simak, Ellis, Ian O, Mongan, Nigel P, Green, Andrew R, Rakha, Emad A
© 2019, The Author(s), under exclusive licence to Cancer Research UK. Background: Retinoid X Receptor Gamma (RXRG) is a member of the nuclear receptor superfamily and plays a role in tumour suppression. This study aims to explore the prognostic sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::83d3c48dd0db385759b0d219c89e703f
Autor:
Joseph, Chitra, Arshad, Maariya, Kurozomi, Sasagu, Althobiti, Maryam, Miligy, Islam M., Al-Izzi, Sara, Toss, Michael S., Goh, Fang Qin, Johnston, Simon J., Martin, Stewart G., Ellis, Ian O., Mongan, Nigel P., Green, Andrew R., Rakha, Emad A.
PurposeCD133/ prominin 1 is a cancer stem cell marker associated with cancer progression and patient outcome in a variety of solid tumours, but its role in invasive breast cancer (BC) remains obscure. The current study aims to assess the prognostic v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6351c9a2b481521cfc8c779945b48acf
Autor:
Perry, Richard J, Tamborska, Arina, Singh, Bhagteshwar, Craven, Brian, Marigold, Richard, Arthur-Farraj, Peter, Yeo, Jing Ming, Zhang, Liqun, Hassan-Smith, Ghaniah, Jones, Matthew, Hutchcroft, Christopher, Hobson, Esther, Warcel, Dana, White, Daniel, Ferdinand, Phillip, Webb, Alastair, Solomon, Tom, Scully, Marie, Werring, David J, Roffe, Christine, Al-izzi, Sara, Baheerathan, Aravindhan, Banerjee, Soma, Benson, Gary, Boshier, Claudia, Buddha, Sandeep, Burley, Nathan, Cameron Smail, Ruaridh, Chandratheva, Arvind, Chudakou, Pavel, Clatworthy, Philip, Coles, Alasdair, Cox, Thomas, Dasgupta, Ranjit, Davenport, Richard, Devine, Darrell, Fenlon, Stephen, Gabriel, Carolyn, Ghatala, Rita, Hall, Claire, Hargovan, Milan, Harkness, Kirsty, Harvey, Ian, Hicken, Lucy, Howaniec, Laura, Ibnouf, Abubaker, Idrovo, Luis, Ingle, Gordon, Kyan Lee, Yong, Lang, Ailidh, McBride, Simon, McLeod, Malcolm, Medlock, Ruth, Mehta, Puja, Morrison, Ian, Muddegowda, Girish, Muzerengi, Sharon, Pang, Donald, Periyasamy, Gopinath, Preston, Gavin, Priestley, Naomi, Revicka, Lydia, Saber, Sadia, Smith, Elliott, Sorour, Youssef, Spooner, Oliver, Stone, Jon, Sztriha, Laszlo, Thambirajah, Narmathey, Thomas, Rhys, Veale, David, Wall, Jasmine, White, Sarah, White, James, Yusoff, Syarah, Zambreanu, Laura
Publikováno v:
The Lancet; September-October 2021, Vol. 398 Issue: 10306 p1147-1156, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joseph C; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Al-Izzi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Alsaleem M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Kurozumi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Toss MS; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt., Arshad M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Goh FQ; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Alshankyty IM; Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia., Aleskandarany MA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt., Ali S; Faculty of Medicine, Department of Surgery & Cancer, Imperial College London, London, UK., Ellis IO; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Mongan NP; Cancer Biology and Translational Research, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, NY, 10065, USA., Green AR; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK., Rakha EA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham, UK. Emad.Rakha@nottingham.ac.uk.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt. Emad.Rakha@nottingham.ac.uk.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Oct; Vol. 121 (9), pp. 776-785. Date of Electronic Publication: 2019 Sep 27.
Autor:
Joseph C; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Arshad M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Kurozomi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan., Althobiti M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Miligy IM; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El-kom, Al Minufiyah, Egypt., Al-Izzi S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Toss MS; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El-kom, Al Minufiyah, Egypt., Goh FQ; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Johnston SJ; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Martin SG; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Ellis IO; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, NG5 1PB, UK., Mongan NP; Cancer Biology and Translational Research, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.; Department of Pharmacology, Weill Cornell Medicine, 10065, New York, NY, USA., Green AR; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK., Rakha EA; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. Emad.Rakha@nottingham.ac.uk.; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El-kom, Al Minufiyah, Egypt. Emad.Rakha@nottingham.ac.uk.; Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, NG5 1PB, UK. Emad.Rakha@nottingham.ac.uk.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Apr; Vol. 174 (2), pp. 387-399. Date of Electronic Publication: 2018 Dec 15.